One study reported that carvacrol ameliorates acute campylobacteriosis by reducing the serum levels of interferon-gamma (IFN-γ), TNF, monocyte chemoattractant protein-1 (MCP-1), and IL-614. This evidence concerns the gene IFNG and campylobacteriosis.